first, aSpanish post-exposure prophylaxis trialthat was also negative. Then there was theRecovery Trialfrom the UK. Most recently, last week theNew England Journal of Medicinepublished aclinical trialof 667 patients with mild-to-moderate COVID-19 randomized to receive placebo or hydroxychloroqu...